The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global market for Biktarvy was valued at US$ 15760 million in the year 2024 and is projected to reach a revised size of US$ 19070 million by 2031, growing at a CAGR of 2.7% during the forecast period.
Biktarvy (Chinese trade name: Bituowei) is a fixed-dose combination antiretroviral drug used to treat human immunodeficiency virus type 1 (HIV-1) infection. It consists of three active ingredients: Bictegravir (an integrase strand transfer inhibitor), Emtricitabine (a nucleoside reverse transcriptase inhibitor), and Tenofovir Alafenamide (a nucleoside reverse transcriptase inhibitor). Biktarvy is indicated for adult and pediatric patients weighing at least 14 kg, with no history of treatment failure and no known resistance mutations to its components. The drug is taken orally once daily as a complete antiretroviral treatment regimen. Biktarvy was approved for marketing by the U.S. Food and Drug Administration (FDA) in February 2018, and was subsequently approved in many countries and regions, and was included in multiple treatment guidelines, becoming one of the first-line treatment options for HIV-1 infection.
North American market for Biktarvy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biktarvy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Biktarvy include Gilead Sciences, ABACUS MEDICINE, Hetero Drugs, Gador SA, BMODESTO, Medcorp Technologies, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biktarvy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biktarvy.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Biktarvy competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The Biktarvy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biktarvy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biktarvy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Gilead Sciences
ABACUS MEDICINE
Hetero Drugs
Gador SA
BMODESTO
Medcorp Technologies
Segment by Type
Brands Drug
Generic Drugs
Segment by Application
Hospitals
Retail Pharmacy
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biktarvy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biktarvy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global market for Biktarvy was valued at US$ 15760 million in the year 2024 and is projected to reach a revised size of US$ 19070 million by 2031, growing at a CAGR of 2.7% during the forecast period.
Biktarvy (Chinese trade name: Bituowei) is a fixed-dose combination antiretroviral drug used to treat human immunodeficiency virus type 1 (HIV-1) infection. It consists of three active ingredients: Bictegravir (an integrase strand transfer inhibitor), Emtricitabine (a nucleoside reverse transcriptase inhibitor), and Tenofovir Alafenamide (a nucleoside reverse transcriptase inhibitor). Biktarvy is indicated for adult and pediatric patients weighing at least 14 kg, with no history of treatment failure and no known resistance mutations to its components. The drug is taken orally once daily as a complete antiretroviral treatment regimen. Biktarvy was approved for marketing by the U.S. Food and Drug Administration (FDA) in February 2018, and was subsequently approved in many countries and regions, and was included in multiple treatment guidelines, becoming one of the first-line treatment options for HIV-1 infection.
North American market for Biktarvy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biktarvy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Biktarvy include Gilead Sciences, ABACUS MEDICINE, Hetero Drugs, Gador SA, BMODESTO, Medcorp Technologies, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biktarvy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biktarvy.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Biktarvy competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The Biktarvy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biktarvy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biktarvy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Gilead Sciences
ABACUS MEDICINE
Hetero Drugs
Gador SA
BMODESTO
Medcorp Technologies
Segment by Type
Brands Drug
Generic Drugs
Segment by Application
Hospitals
Retail Pharmacy
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biktarvy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biktarvy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Biktarvy Market Overview
1.1 Product Definition
1.2 Biktarvy by Type
1.2.1 Global Biktarvy Market Value Comparison by Type (2024 VS 2031)
1.2.2 Brands Drug
1.2.3 Generic Drugs
1.3 Biktarvy by Application
1.3.1 Global Biktarvy Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Biktarvy Market Size Estimates and Forecasts
1.4.1 Global Biktarvy Revenue 2020-2031
1.4.2 Global Biktarvy Sales 2020-2031
1.4.3 Global Biktarvy Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Biktarvy Market Competition by Manufacturers
2.1 Global Biktarvy Sales Market Share by Manufacturers (2020-2025)
2.2 Global Biktarvy Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Biktarvy Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Biktarvy, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biktarvy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biktarvy, Product Type & Application
2.7 Global Key Manufacturers of Biktarvy, Date of Enter into This Industry
2.8 Global Biktarvy Market Competitive Situation and Trends
2.8.1 Global Biktarvy Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Biktarvy Players Market Share by Revenue
2.8.3 Global Biktarvy Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biktarvy Market Scenario by Region
3.1 Global Biktarvy Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Biktarvy Sales by Region: 2020-2031
3.2.1 Global Biktarvy Sales by Region: 2020-2025
3.2.2 Global Biktarvy Sales by Region: 2026-2031
3.3 Global Biktarvy Revenue by Region: 2020-2031
3.3.1 Global Biktarvy Revenue by Region: 2020-2025
3.3.2 Global Biktarvy Revenue by Region: 2026-2031
3.4 North America Biktarvy Market Facts & Figures by Country
3.4.1 North America Biktarvy Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Biktarvy Sales by Country (2020-2031)
3.4.3 North America Biktarvy Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biktarvy Market Facts & Figures by Country
3.5.1 Europe Biktarvy Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Biktarvy Sales by Country (2020-2031)
3.5.3 Europe Biktarvy Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biktarvy Market Facts & Figures by Region
3.6.1 Asia Pacific Biktarvy Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Biktarvy Sales by Region (2020-2031)
3.6.3 Asia Pacific Biktarvy Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Biktarvy Market Facts & Figures by Country
3.7.1 Latin America Biktarvy Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Biktarvy Sales by Country (2020-2031)
3.7.3 Latin America Biktarvy Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Biktarvy Market Facts & Figures by Country
3.8.1 Middle East and Africa Biktarvy Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Biktarvy Sales by Country (2020-2031)
3.8.3 Middle East and Africa Biktarvy Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biktarvy Sales by Type (2020-2031)
4.1.1 Global Biktarvy Sales by Type (2020-2025)
4.1.2 Global Biktarvy Sales by Type (2026-2031)
4.1.3 Global Biktarvy Sales Market Share by Type (2020-2031)
4.2 Global Biktarvy Revenue by Type (2020-2031)
4.2.1 Global Biktarvy Revenue by Type (2020-2025)
4.2.2 Global Biktarvy Revenue by Type (2026-2031)
4.2.3 Global Biktarvy Revenue Market Share by Type (2020-2031)
4.3 Global Biktarvy Price by Type (2020-2031)
5 Segment by Application
5.1 Global Biktarvy Sales by Application (2020-2031)
5.1.1 Global Biktarvy Sales by Application (2020-2025)
5.1.2 Global Biktarvy Sales by Application (2026-2031)
5.1.3 Global Biktarvy Sales Market Share by Application (2020-2031)
5.2 Global Biktarvy Revenue by Application (2020-2031)
5.2.1 Global Biktarvy Revenue by Application (2020-2025)
5.2.2 Global Biktarvy Revenue by Application (2026-2031)
5.2.3 Global Biktarvy Revenue Market Share by Application (2020-2031)
5.3 Global Biktarvy Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Company Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Biktarvy Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Gilead Sciences Biktarvy Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 ABACUS MEDICINE
6.2.1 ABACUS MEDICINE Company Information
6.2.2 ABACUS MEDICINE Description and Business Overview
6.2.3 ABACUS MEDICINE Biktarvy Sales, Revenue and Gross Margin (2020-2025)
6.2.4 ABACUS MEDICINE Biktarvy Product Portfolio
6.2.5 ABACUS MEDICINE Recent Developments/Updates
6.3 Hetero Drugs
6.3.1 Hetero Drugs Company Information
6.3.2 Hetero Drugs Description and Business Overview
6.3.3 Hetero Drugs Biktarvy Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hetero Drugs Biktarvy Product Portfolio
6.3.5 Hetero Drugs Recent Developments/Updates
6.4 Gador SA
6.4.1 Gador SA Company Information
6.4.2 Gador SA Description and Business Overview
6.4.3 Gador SA Biktarvy Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Gador SA Biktarvy Product Portfolio
6.4.5 Gador SA Recent Developments/Updates
6.5 BMODESTO
6.5.1 BMODESTO Company Information
6.5.2 BMODESTO Description and Business Overview
6.5.3 BMODESTO Biktarvy Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BMODESTO Biktarvy Product Portfolio
6.5.5 BMODESTO Recent Developments/Updates
6.6 Medcorp Technologies
6.6.1 Medcorp Technologies Company Information
6.6.2 Medcorp Technologies Description and Business Overview
6.6.3 Medcorp Technologies Biktarvy Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Medcorp Technologies Biktarvy Product Portfolio
6.6.5 Medcorp Technologies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biktarvy Industry Chain Analysis
7.2 Biktarvy Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biktarvy Production Mode & Process Analysis
7.4 Biktarvy Sales and Marketing
7.4.1 Biktarvy Sales Channels
7.4.2 Biktarvy Distributors
7.5 Biktarvy Customer Analysis
8 Biktarvy Market Dynamics
8.1 Biktarvy Industry Trends
8.2 Biktarvy Market Drivers
8.3 Biktarvy Market Challenges
8.4 Biktarvy Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Biktarvy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Biktarvy Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Biktarvy Market Competitive Situation by Manufacturers in 2024
Table 4. Global Biktarvy Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Biktarvy Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Biktarvy Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Biktarvy Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Biktarvy Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Biktarvy, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Biktarvy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Biktarvy, Product Type & Application
Table 12. Global Key Manufacturers of Biktarvy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biktarvy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biktarvy as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Biktarvy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Biktarvy Sales by Region (2020-2025) & (K Units)
Table 18. Global Biktarvy Sales Market Share by Region (2020-2025)
Table 19. Global Biktarvy Sales by Region (2026-2031) & (K Units)
Table 20. Global Biktarvy Sales Market Share by Region (2026-2031)
Table 21. Global Biktarvy Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Biktarvy Revenue Market Share by Region (2020-2025)
Table 23. Global Biktarvy Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Biktarvy Revenue Market Share by Region (2026-2031)
Table 25. North America Biktarvy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Biktarvy Sales by Country (2020-2025) & (K Units)
Table 27. North America Biktarvy Sales by Country (2026-2031) & (K Units)
Table 28. North America Biktarvy Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Biktarvy Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Biktarvy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Biktarvy Sales by Country (2020-2025) & (K Units)
Table 32. Europe Biktarvy Sales by Country (2026-2031) & (K Units)
Table 33. Europe Biktarvy Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Biktarvy Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Biktarvy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Biktarvy Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Biktarvy Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Biktarvy Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Biktarvy Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Biktarvy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Biktarvy Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Biktarvy Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Biktarvy Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Biktarvy Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Biktarvy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Biktarvy Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Biktarvy Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Biktarvy Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Biktarvy Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Biktarvy Sales (K Units) by Type (2020-2025)
Table 51. Global Biktarvy Sales (K Units) by Type (2026-2031)
Table 52. Global Biktarvy Sales Market Share by Type (2020-2025)
Table 53. Global Biktarvy Sales Market Share by Type (2026-2031)
Table 54. Global Biktarvy Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Biktarvy Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Biktarvy Revenue Market Share by Type (2020-2025)
Table 57. Global Biktarvy Revenue Market Share by Type (2026-2031)
Table 58. Global Biktarvy Price (US$/Unit) by Type (2020-2025)
Table 59. Global Biktarvy Price (US$/Unit) by Type (2026-2031)
Table 60. Global Biktarvy Sales (K Units) by Application (2020-2025)
Table 61. Global Biktarvy Sales (K Units) by Application (2026-2031)
Table 62. Global Biktarvy Sales Market Share by Application (2020-2025)
Table 63. Global Biktarvy Sales Market Share by Application (2026-2031)
Table 64. Global Biktarvy Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Biktarvy Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Biktarvy Revenue Market Share by Application (2020-2025)
Table 67. Global Biktarvy Revenue Market Share by Application (2026-2031)
Table 68. Global Biktarvy Price (US$/Unit) by Application (2020-2025)
Table 69. Global Biktarvy Price (US$/Unit) by Application (2026-2031)
Table 70. Gilead Sciences Company Information
Table 71. Gilead Sciences Description and Business Overview
Table 72. Gilead Sciences Biktarvy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Gilead Sciences Biktarvy Product
Table 74. Gilead Sciences Recent Developments/Updates
Table 75. ABACUS MEDICINE Company Information
Table 76. ABACUS MEDICINE Description and Business Overview
Table 77. ABACUS MEDICINE Biktarvy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. ABACUS MEDICINE Biktarvy Product
Table 79. ABACUS MEDICINE Recent Developments/Updates
Table 80. Hetero Drugs Company Information
Table 81. Hetero Drugs Description and Business Overview
Table 82. Hetero Drugs Biktarvy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Hetero Drugs Biktarvy Product
Table 84. Hetero Drugs Recent Developments/Updates
Table 85. Gador SA Company Information
Table 86. Gador SA Description and Business Overview
Table 87. Gador SA Biktarvy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Gador SA Biktarvy Product
Table 89. Gador SA Recent Developments/Updates
Table 90. BMODESTO Company Information
Table 91. BMODESTO Description and Business Overview
Table 92. BMODESTO Biktarvy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. BMODESTO Biktarvy Product
Table 94. BMODESTO Recent Developments/Updates
Table 95. Medcorp Technologies Company Information
Table 96. Medcorp Technologies Description and Business Overview
Table 97. Medcorp Technologies Biktarvy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Medcorp Technologies Biktarvy Product
Table 99. Medcorp Technologies Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Biktarvy Distributors List
Table 103. Biktarvy Customers List
Table 104. Biktarvy Market Trends
Table 105. Biktarvy Market Drivers
Table 106. Biktarvy Market Challenges
Table 107. Biktarvy Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Biktarvy
Figure 2. Global Biktarvy Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biktarvy Market Share by Type: 2024 & 2031
Figure 4. Brands Drug Product Picture
Figure 5. Generic Drugs Product Picture
Figure 6. Global Biktarvy Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Biktarvy Market Share by Application: 2024 & 2031
Figure 8. Hospitals
Figure 9. Retail Pharmacy
Figure 10. Others
Figure 11. Global Biktarvy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Biktarvy Market Size (2020-2031) & (US$ Million)
Figure 13. Global Biktarvy Sales (2020-2031) & (K Units)
Figure 14. Global Biktarvy Average Price (US$/Unit) & (2020-2031)
Figure 15. Biktarvy Report Years Considered
Figure 16. Biktarvy Sales Share by Manufacturers in 2024
Figure 17. Global Biktarvy Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Biktarvy Players: Market Share by Revenue in Biktarvy in 2024
Figure 19. Biktarvy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Biktarvy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Biktarvy Sales Market Share by Country (2020-2031)
Figure 22. North America Biktarvy Revenue Market Share by Country (2020-2031)
Figure 23. United States Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Biktarvy Sales Market Share by Country (2020-2031)
Figure 26. Europe Biktarvy Revenue Market Share by Country (2020-2031)
Figure 27. Germany Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Biktarvy Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Biktarvy Revenue Market Share by Region (2020-2031)
Figure 34. China Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Biktarvy Sales Market Share by Country (2020-2031)
Figure 42. Latin America Biktarvy Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Biktarvy Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Biktarvy Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Biktarvy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Biktarvy by Type (2020-2031)
Figure 53. Global Revenue Market Share of Biktarvy by Type (2020-2031)
Figure 54. Global Biktarvy Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Biktarvy by Application (2020-2031)
Figure 56. Global Revenue Market Share of Biktarvy by Application (2020-2031)
Figure 57. Global Biktarvy Price (US$/Unit) by Application (2020-2031)
Figure 58. Biktarvy Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
